2024³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Adult ADHD ½ÉÆ÷Áö¿ò : 2024-05-24
±³À°ÀÏÀÚ : 2024-05-24
±³À°Àå¼Ò : ¼¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽÇ
±³À°ÁÖÁ¦ : 2024³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Adult ADHD ½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ
´ã´çÀÚ : À̼¼Àº
¿¬¶ôó : 02-784-2742
À̸ÞÀÏ : secretariat@kcnp.or.kr
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í »çÀüµî·Ïºñ Æò»ýȸ¿ø ¸éÁ¦/Á¤È¸¿ø 20,000¿ø/ºñȸ¿ø 30,000¿ø/ÁØȸ¿ø¹×±âŸ10,000¿ø/´çÀϵî·Ïºñ Æò»ýȸ¿ø 10,000¿ø/Á¤È¸¿ø 30,000¿ø/ºñȸ¿ø 50,000¿ø/ÁØȸ¿ø¹×±âŸ20,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 24ÀÏ ÄÁº¥¼ÇȦ 14:00~14:30 MTA ¿¬±¸ÀÇ ÀÇ¹Ì ¹× Ãʱ⠰á°ú ¾çÂù¸ð(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 05¿ù 24ÀÏ ÄÁº¥¼ÇȦ 14:30~15:00 MTAÀÇ 2010³â´ë °á°ú ±è½Â°ï(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 05¿ù 24ÀÏ ÄÁº¥¼ÇȦ 15:00~15:30 MTAÀÇ 2020³â´ë °á°ú ¹Ú¼º¿ë(°è¿äº´¿ø)
±³À°½Ã°£ 05¿ù 24ÀÏ ´ëȸÀÇ½Ç 14:00~14:20 Prevalence and comorbidities of adult ADHD in a community sample ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 05¿ù 24ÀÏ ´ëȸÀÇ½Ç 14:20~14:40 Prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review ÃÖ¿ø¼®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05¿ù 24ÀÏ ´ëȸÀÇ½Ç 14:40~15:05 Comparison between Atomoxetine & OROS Methylphenidate as an adjunctive to SSRIs in adult ADHD with comorbid partially responsive MDD ¿ì¿µ¼·(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05¿ù 24ÀÏ ´ëȸÀÇ½Ç 15:05~15:30 Cognitive developmental trajectories in adult ADHD patients and controls: A comparative study È«Áö¼±(Áß¾ÓÀÇ´ë)
ÈÞ½Ä 05¿ù 24ÀÏ 15:30~15:40 ()
±³À°½Ã°£ 05¿ù 24ÀÏ ÄÁº¥¼ÇȦ 15:40~16:10 ¼ºÀÎ ADHD´Â ¼Ò¾Æ±â ¹ßº´ÀÇ Áö¼ÓÀÌ´Ù À¯ÇÑÀÍ(¼¿ï¿ì¸®¾ÆÀÌÀÇ¿ø)
±³À°½Ã°£ 05¿ù 24ÀÏ ÄÁº¥¼ÇȦ 16:10~16:40 ¼ºÀÎ ADHD´Â ¼ºÀα⠹ߺ´ÀÌ´Ù ¼ºÇü¸ð(¼øõÇâÀÇ´ë)
Åä·Ð 05¿ù 24ÀÏ 16:40~17:10 Interactive discussion ()
±³À°½Ã°£ 05¿ù 24ÀÏ ´ëȸÀÇ½Ç 15:40~16:10 ³úÆĸ¦ ÀÌ¿ëÇÑ Æò°¡ ¾ç¿ëÁØ(¿À´ÃÁ¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 05¿ù 24ÀÏ ´ëȸÀÇ½Ç 16:10~16:40 ½Å°æÀÎÁö±â´É°Ë»ç¸¦ ÀÌ¿ëÇÑ Æò°¡ ¹®°¡¿µ(°è¿äº´¿ø ÀÓ»ó½É¸®)
±³À°½Ã°£ 05¿ù 24ÀÏ ´ëȸÀÇ½Ç 16:40~17:10 Mobile appÀ» È°¿ëÇÑ ¼ºÀÎ ADHD ¼±º°°Ë»ç È«Á¤¿Ï(Àͻ꺴¿ø)